|
Factors
|
N = 124 (%)
|
Disease free survival %
|
Median months (95% CI)
|
Log rankP value
|
|---|
|
1 yr
|
2 yrs
|
3 yrs
|
5 yrs
|
10 yrs
|
|---|
|
All
|
124 (100)
|
81.2
|
67.4
|
62.1
|
60.2
|
45.6
|
72.0
|
NA
|
|
Age (yrs)
|
|
≤ 45
|
60 (48.4)
|
81.3
|
69.4
|
64.2
|
64.2
|
40.1
|
66 (52-79)
|
0.917
|
|
> 45
|
64 (51.6)
|
81.1
|
65.4
|
60.3
|
55.4
|
47.7
|
103
|
|
Gender
|
|
Male
|
64 (51.6)
|
76.2
|
63.0
|
60.3
|
60.3
|
41.4
|
72 (4-139)
|
0.41
|
|
Female
|
60 (48.4)
|
86.4
|
72.1
|
63.8
|
59.3
|
51.9
|
NA
|
|
Residence
|
|
Urban
|
66 (53.2)
|
86.0
|
71.3
|
64.5
|
64.5
|
54.5
|
NA
|
0.225
|
|
Rural
|
58 (48.4)
|
81.0
|
63.0
|
59.9
|
55.3
|
NA
|
62 (21-102)
|
|
DM
|
|
- ve
|
109 (87.9)
|
81.3
|
67.5
|
64.4
|
62.3
|
47.2
|
103
|
0.414
|
|
+ ve
|
15 (12.1)
|
80.0
|
66.7
|
44.4
|
NA
|
NA
|
30 (21-38)
|
|
HTN
|
|
- ve
|
110 (88.7)
|
81.7
|
67.1
|
61.1
|
58.9
|
41.9
|
72 (14.8-129.1)
|
0.434
|
|
+ ve
|
14 (11.3)
|
76.9
|
69.2
|
69.2
|
69.2
|
69.2
|
NA
|
|
Family history
|
|
- ve
|
103 (83.1)
|
79.2
|
65.9
|
61.3
|
59.0
|
44.6
|
103 (28.2-177.5)
|
0.804
|
|
+ ve
|
21 (16.9)
|
90.5
|
73.5
|
65.3
|
65.3
|
49.0
|
NA
|
|
Smoking
|
|
- ve
|
88 (71)
|
94.4
|
75.6
|
73.4
|
70.2
|
53.0
|
NA
|
0.078
|
|
+ ve
|
36 (29)
|
74.3
|
57.0
|
52.6
|
52.6
|
39.5
|
103 (0-225)
|
|
PS
|
|
0
|
56 (45.2)
|
89.3
|
81.7
|
79.2
|
75.5
|
51.0
|
NA
|
0.016
|
|
I
|
48 (38.7)
|
76.6
|
56.6
|
49.0
|
49.0
|
49.0
|
32
|
|
II
|
20 (16.1)
|
68.6
|
52.3
|
43.5
|
43.5
|
NA
|
30 (8.1-51.9)
|
|
Pathology
|
|
Adenocarcinoma
|
105 (84.7)
|
82.5
|
68.5
|
62.3
|
60.2
|
47.5
|
72
|
0.713
|
|
Mucinous
|
19 (15.3)
|
73.7
|
61.4
|
61.4
|
61.4
|
40.6
|
103 (0-249)
|
|
Grade
|
|
I-II
|
109 (87.9)
|
81.3
|
68.7
|
64.2
|
62.1
|
46.4
|
102
|
0.425
|
|
III
|
15 (12.1)
|
80.0
|
58.7
|
46.9
|
46.9
|
NA
|
32
|
|
T. stage
|
|
T3
|
84 (67.7)
|
85.4
|
76.7
|
69.5
|
66.8
|
45.9
|
103
|
0.058
|
|
T4
|
40 (32.3)
|
75.0
|
46.0
|
46.0
|
46.0
|
46.0
|
21
|
|
Dissected LN
|
|
< 12
|
60 (48.4)
|
81.7
|
69.5
|
64.5
|
60.9
|
44.3
|
66 (49.7-82.2)
|
0.89
|
|
≥ 12
|
64 (51.6)
|
80.7
|
65.4
|
60.2
|
60.2
|
48.1
|
103
|
|
Adjuvant
|
|
No
|
30 (24.2)
|
88.6
|
70.8
|
61.0
|
54.2
|
54.2
|
NA
|
0.787
|
|
Yes
|
94 (75.8)
|
79.4
|
66.4
|
61.1
|
61.1
|
43.4
|
72 (25.3-118.7)
|
- The data in boldface denotes the presence of statistically significant difference between the studied groups
